Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer

Degree of Early Estrogen Response Predict Survival after Endocrine Therapy in Primary and Metastatic ER-Positive Breast Cancer

Endocrine therapy is the gold-standard treatment for ER-positive/HER2-negative breast cancer. Although its clear benefit, patient compliance is poor (50–80%) due to its long administration period and adverse effects. Therefore, a predictive biomarker that can predict whether endocrine therapy is tru...

Full description

Bibliographic Details
Main Authors: Masanori Oshi, Yoshihisa Tokumaru, Fernando A. Angarita, Li Yan, Ryusei Matsuyama, Itaru Endo, Kazuaki Takabe
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
biomarker
GSEA
GSVA
estrogen response
endocrine
treatment response
Online Access:https://www.mdpi.com/2072-6694/12/12/3557

Internet

https://www.mdpi.com/2072-6694/12/12/3557

Similar Items